PedAM
Pediatric Disease Annotations & Medicines
| Disease | nephrotic syndrome |
| Symptom | C0242339|dyslipidemia |
| Sentences | 3 |
| PubMedID- 26149129 | The following patients were excluded from the study: (1) those treated with lipid-lowering drugs (statins, pufas, fibrates, nicotinic acid, colestyramine, or probucol), (2) those with dyslipidemia associated with hypothyroidism, nephrotic syndrome, gallbladder obstruction, biliary disease, pancreatitis, or immunologic abnormalities such as collagen diseases, (3) those with dyslipidemia induced by steroids or other drugs, (4) those with severe liver dysfunction, (5) alcoholism or heavy alcohol intake, (6) any other reason for which the patient was considered inappropriate for this study by the attending physician. |
| PubMedID- 24535024 | Secondary dyslipidemia associated with refractory nephrotic syndrome (ns), typically that due to focal segmental glomerulosclerosis (fsgs), persists over a long period, causes the progression of cardiovascular disease with a course similar to arteriosclerotic lesions due to primary dyslipidemia, and exacerbates damage to affected glomeruli and renal tubules. |
| PubMedID- 23864805 | Hypoalbuminemia is often accompanied with dyslipidemia in patients with nephrotic syndrome and dialysis patients. |
Page: 1